Clinical Trial Update: Technology Delivered Diabetes-Modified Behavioral Activation Treatment [NA]

View source ↗

Summary

The SUNY Buffalo study evaluating a technology-delivered diabetes-modified behavioral activation treatment for type 2 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Diabetes Mellitus, Type 2 | NA | Status: TERMINATED